Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panelJann N. Sarkaria, C. David James, Patrick T. Grogan et al.|Molecular Cancer Therapeutics|2007Cited by 203
PTEN Loss Does Not Predict for Response to RAD001 (Everolimus) in a Glioblastoma Orthotopic Xenograft Test PanelLin Yang, Jann N. Sarkaria|Clinical Cancer Research|2008Cited by 60